Accordingly, this study evaluated the association of the genotype for the CFH, ARMS2, HTRA1, VEGF-A, and KDR genes with the change in visual acuity and macular thickness after 6 months of intravitreal ranibizumab therapy for exudative AMD in a Korean population. This evidence concerns the gene HTRA1 and age-related macular degeneration.